Evidence map›Paper›PMID 28706339›Full record

ArticleJournal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986)2017

Expansion of bone marrow-derived human mesenchymal stem/stromal cells (hMSCs) using a two-phase liquid/liquid system.

Mariana P Hanga, Halina Murasiewicz, Andrzej W Pacek, Alvin W Nienow, Karen Coopman, Christopher J Hewitt

Open access · hybridAbstract read
In one paragraph

Article in Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. A preview of selected articles-September 2021.Stem cells translational medicine · 2021
    Article
  4. Article
  5. Expansion of human mesenchymal stem/stromal cells on temporary liquid microcarriers.Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986) · 2021
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mariana P HangaCentre for Biological EngineeringLoughborough UniversityLoughboroughUK.
Halina MurasiewiczSchool of Chemical EngineeringUniversity of BirminghamBirminghamUK.
Andrzej W PacekSchool of Chemical EngineeringUniversity of BirminghamBirminghamUK.
Alvin W NienowCentre for Biological EngineeringLoughborough UniversityLoughboroughUK.
Karen CoopmanCentre for Biological EngineeringLoughborough UniversityLoughboroughUK.
Christopher J HewittCentre for Biological EngineeringLoughborough UniversityLoughboroughUK.
Loughborough University · GBUniversity of Birmingham · GBAston University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman mesenchymal stem/stromal cells (hMSCs) are at the forefront of regenerative medicine applications due to their relatively easy isolation and availability in adults, potential to differentiate and to secrete a range of trophic factors that could determine specialised tissue regeneration. To date, hMSCs have been successfully cultured in vitro on substrates such as polystyrene dishes (TCPS) or microcarriers. However, hMSC sub-cultivation and harvest typically employs proteolytic enzymes that act by cleaving important cell membrane proteins resulting in long-term cell damage. In a process where the cells themselves are the product, a non-enzymatic and non-damaging harvesting approach is desirable.

resultsAn alternative system for hMSC expansion and subsequent non-enzymatic harvest was investigated here. A liquid/liquid two-phase system was proposed, comprising a selected perfluorocarbon (FC40) and growth medium (DMEM). The cells exhibited similar cell morphologies compared with TCPS. Moreover, they retained their identity and differentiation potential post-expansion and post-harvest. Further, no significant difference was found when culturing hMSCs in the culture systems prepared with either fresh or recycled FC40 perfluorocarbon.

conclusionsThese findings make the FC40/DMEM system an attractive alternative for traditional cell culture substrates due to their ease of cell recovery and recyclability, the latter impacting on overall process costs. © 2017 The Authors.

Indexed as

expansionhuman bone marrow‐derived mesenchymal stem/stromal cells (hMSCs)liquid/liquid interfaceperfluorocarbonstwo‐phase system

Identifiers

PMID28706339
PMCPMC5485050
OpenAlexW2609041774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.